Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.
Franken MD, van Rooijen EM, May AM, Koffijberg H, van Tinteren H, Mol L, Ten Tije AJ, Creemers GJ, van der Velden AMT, Tanis BC, Uyl-de Groot CA, Punt CJA, Koopman M, van Oijen MGH. Franken MD, et al. Among authors: van oijen mgh, van rooijen em, van tinteren h, van der velden amt. Eur J Cancer. 2017 Apr;75:204-212. doi: 10.1016/j.ejca.2017.01.019. Epub 2017 Feb 24. Eur J Cancer. 2017. PMID: 28237866 Clinical Trial.
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
Verboom P, van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, van Mourik JC, Postmus PE, Boers M, Grijseels EW, Teule GJ, Uyl-de Groot CA; PLUS study group. Verboom P, et al. Among authors: van den bergh jh, van velthoven pc, van mourik jc, van tinteren h. Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1444-9. doi: 10.1007/s00259-003-1199-9. Epub 2003 May 29. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579081 Clinical Trial.
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.
Herder GJ, Kramer H, Hoekstra OS, Smit EF, Pruim J, van Tinteren H, Comans EF, Verboom P, Uyl-de Groot CA, Welling A, Paul MA, Boers M, Postmus PE, Teule GJ, Groen HJ; POORT Study Group. Herder GJ, et al. Among authors: van tinteren h. J Clin Oncol. 2006 Apr 20;24(12):1800-6. doi: 10.1200/JCO.2005.02.4695. Epub 2006 Mar 27. J Clin Oncol. 2006. PMID: 16567772 Clinical Trial.
A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy.
de Bree R, van der Putten L, Hoekstra OS, Kuik DJ, Uyl-de Groot CA, van Tinteren H, Leemans CR, Boers M; RELAPS Study Group. de Bree R, et al. Among authors: van der putten l, van tinteren h. Contemp Clin Trials. 2007 Nov;28(6):705-12. doi: 10.1016/j.cct.2007.03.009. Epub 2007 Mar 21. Contemp Clin Trials. 2007. PMID: 17459783 Clinical Trial.
Prospective cost-effectiveness analysis of genomic profiling in breast cancer.
Retèl VP, Joore MA, Drukker CA, Bueno-de-Mesquita JM, Knauer M, van Tinteren H, Linn SC, van Harten WH. Retèl VP, et al. Among authors: van harten wh, van tinteren h. Eur J Cancer. 2013 Dec;49(18):3773-9. doi: 10.1016/j.ejca.2013.08.001. Epub 2013 Aug 27. Eur J Cancer. 2013. PMID: 23992641
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Badrising S, van der Noort V, van Oort IM, van den Berg HP, Los M, Hamberg P, Coenen JL, van den Eertwegh AJ, de Jong IJ, Kerver ED, van Tinteren H, Bergman AM. Badrising S, et al. Among authors: van oort im, van den eertwegh aj, van den berg hp, van tinteren h, van der noort v. Cancer. 2014 Apr 1;120(7):968-75. doi: 10.1002/cncr.28518. Epub 2013 Dec 30. Cancer. 2014. PMID: 24382803 Free article.
324 results